A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
Clinical trial NCT07379333 · RECRUITING
Trial details
- NCT number
- NCT07379333
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-13
- Primary completion
- 2027-11-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.